bioRxivGenomicsPreprint
Context-dependent regulatory variants in Alzheimer's disease
Ziheng CheniD, Yaxuan LiuiD, Ashley R. BrowniD, Heather H. SestiliiD, Easwaran RamamurthyiD, Xushen XiongiD, Dmitry ProkopenkoiD, BaDoi N. PhaniD, Lahari GadeyiD, Robert van de WeerdiD, Karsen E. ShogeriD, Peinan HuiD, Shiyu WangiD, Irene M. KaplowiD, Rachel A. GottschalkiD, Li‐Huei TsaiiD, Lars BertramiD, Yoshihide Hayashizaki, Rudolph E. TanziiD, M KellisiD, Andreas R. PfenningiD
Abstract
Noncoding genetic variants underlie many complex diseases, yet identifying and interpreting their functional impacts remains challenging. Late-onset Alzheimers disease (LOAD), a polygenic neurodegenerative disorder, exemplifies this challenge. The disease is strongly associated with noncoding variation, including common variants enriched in microglial enhancers and rare variants nominated at loci implicated in neurodevelopment and synaptic function. These variants may perturb regulatory sequences by disrupting transcription factor (TF) motifs or altering local regulatory sequence context, with potential consequences for gene expression and chromatin accessibility. However, assessing their impact is complicated by the context-dependent functions of regulatory sequences, underscoring the need to systematically examine variant effects across diverse tissues, cell types, and cellular states. Here, we combined in vitro and in vivo massively parallel reporter assays (MPRAs) with interpretable machine-learning models to systematically characterize common and rare variants across myeloid and neuron-enriched neural contexts. Parallel profiling of variants in four immune states in vitro and three mouse brain regions in vivo revealed that individual variants can differentially and even oppositely modulate reporter activity across cellular contexts, while a subset showed immune-state-dependent effects. Within the assayed candidate set, the relative effect sizes of common and rare variants reversed between contexts, with common variants showing larger effects in THP-1 macrophages and rare variants in brain tissue. Interpretable sequence-to-function models prioritized context-biased variants and generated motif-level hypotheses, including predicted transcription-factor motif disruption and subtler changes in local motif context. To probe endogenous consequences at a prioritized locus, we used CRISPR interference to perturb a rare-variant-containing enhancer at the SEC63-OSTM1 locus, revealing metabolic and biosynthetic transcriptional programs resembling those induced by SEC63 promoter perturbation, together with a stimulation-specific interferon response. These findings show that LOAD-associated noncoding variants exhibit context-dependent effects on reporter activity and predicted chromatin accessibility, and provide a framework for linking genetic association to regulatory activity, sequence grammar and endogenous transcriptional state.
- organism: human
- assay: DNA methylation
- assay: CRISPR screen
- research focus: differential expression
- research focus: gene regulatory network inference
- approach: machine learning (classical)
- Citations
- 3
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Identification of functional non-coding variants affecting Alzheimer's disease risk by Massively Parallel Reporter Assay
Adam D. Hudgins, Hyun-Kyung Chang, … Yousin Suh·bioRxiv·May 5, 2026
- Deciphering the functional impact of Alzheimers Disease-associated variants in resting and proinflammatory immune cells
Marielle L. Bond, Ivana Yoseli Quiroga, … Hyejung Won·medRxiv·Sep 13, 2024
- Inferring the molecular mechanisms of noncoding Alzheimer’s disease-associated genetic variants
Alexandre Amlie‐Wolf, Mitchell Tang, … Gerard D. Schellenberg·Journal of Alzheimer s DiseasePeer-reviewed·Sep 24, 2019
- Regulatory landscape of Alzheimer's disease variants in human microglia
Chia-Yi Joy Lee, Ashvin Ravi, … Kristen Brennand·medRxiv·Oct 13, 2025
- Allele-specific analysis reveals exon- and cell-type-specific regulatory effects of Alzheimer's disease-associated genetic variants
Liang He, Yury Loika, Alexander M. Kulminski·Translational PsychiatryPeer-reviewed·Apr 18, 2022
- Silencer variants are key drivers of gene upregulation in Alzheimer's disease.
Di Huang, Ivan Ovcharenko·Science AdvancesPeer-reviewed·Feb 11, 2026